Mayukh Sukhatme Roivant Sciences Ltd. (ROIV) insider trading activity

Mayukh Sukhatme is Pres&Chief Investment Officer of Roivant Sciences Ltd.. Currently has a direct ownership of 22.5 Million shares of ROIV, which is worth approximately $252 Million. The most recent transaction as insider was on Jul 26, 2024, when has been sold 18,836,547 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.5M

515.79% 3M change

598.89% 12M change

Total Value Held $252 Million

Mayukh Sukhatme Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 26 2024	BUY Grant, award, or other acquisition	-	18,836,547 Added 45.58%	22,488,532 Common Shares
Mar 30 2024	SELL Payment of exercise price or tax liability	$3,859,863 $10.54 p/Share	366,211 Reduced 9.11%	3,651,985 Common Shares
Mar 30 2024	BUY Exercise of conversion of derivative security	-	729,081 Added 15.36%	4,018,196 Common Shares
Dec 27 2023	BUY Exercise of conversion of derivative security	-	71,365 Added 2.12%	3,289,115 Common Shares
Sep 27 2023	BUY Exercise of conversion of derivative security	-	27,790 Added 0.86%	3,217,750 Common Shares
Aug 27 2023	BUY Exercise of conversion of derivative security	-	22,565 Added 0.7%	3,189,960 Common Shares
Jul 27 2023	BUY Exercise of conversion of derivative security	-	43,212 Added 1.35%	3,167,395 Common Shares
May 27 2023	BUY Exercise of conversion of derivative security	-	99,458 Added 3.09%	3,124,183 Common Shares

Mayukh Sukhatme

Pres&Chief Investment Officer

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account